Insider · CIK 0001902368
Jula Inrig
Files at TVTX (Travere Therapeutics, Inc.). First filing Jan 6, 2025, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TVTX: Travere Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Travere Therapeutics, Inc. | $2.8M 44,674 shares | -31% | +175% from low-7% from high | |
| 0Weak | Travere Therapeutics, Inc. | $12k 815 shares | -1% | +20% from low-38% from high | |
| 22Weak | Travere Therapeutics, Inc. | $60k 2,568 shares | -3% | - | |
| 20Weak | Travere Therapeutics, Inc. | $106k 5,273 shares | -6% | - | |
| 10Weak | Travere Therapeutics, Inc. | $48k 2,506 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +32,395 | $8.93 | $289k | 145,165 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,390 | $62.02 | $1.6M | 119,775 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -17,284 | $62.62 | $1.1M | 102,491 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,600 | $63.69 | $102k | 100,891 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -400 | $65.31 | $26k | 100,491 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -32,395 | $0.00 | $0 | 43,605 | 25 d ago |
| Jul 1, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -815 | $14.65 | $12k | 88,787 | Jul 2, 2025 |
| Feb 10, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock | +8,000 | - | - | 92,170 | Feb 12, 2025 |
| Feb 12, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock | -2,568 | $23.53 | $60k | 89,602 | Feb 12, 2025 |
| Feb 10, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Performance-based restricted stock unitsderivative | -8,000 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Jan 31, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Common Stock10b5-1 | +30,000 | $0.00 | $0 | 89,443 | Feb 4, 2025 |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,207 | $20.12 | $85k | 85,236 | Feb 4, 2025 |
| Feb 4, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,066 | $20.11 | $21k | 84,170 | Feb 4, 2025 |
| Jan 31, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Employee stock option (right to buy)derivative10b5-1 | +100,000 | $0.00 | $0 | 100,000 | Feb 4, 2025 |
| Jan 3, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,066 | $19.10 | $39k | 59,883 | Jan 6, 2025 |
| Jan 6, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -440 | $18.76 | $8,254 | 59,443 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.